These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9375946)

  • 1. Role of beta blockade in the treatment of myocardial ischemia.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1997 Nov; 80(9B):23J-28J. PubMed ID: 9375946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary approaches in medical management of patients with stable coronary artery disease.
    Carbajal EV; Deedwania PC
    Med Clin North Am; 1995 Sep; 79(5):1063-84. PubMed ID: 7674685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
    Fox KM; Mulcahy DA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia.
    Cohn PF
    Clin Ther; 1997; 19 Suppl A():74-91. PubMed ID: 9385506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in the management of coronary artery disease: are we on the verge of a new paradigm shift?
    Elgendy IY; Mahmoud A; Conti CR
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):11-21. PubMed ID: 25174339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
    Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
    Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
    Reyes E; Stirrup J; Roughton M; D'Souza S; Underwood SR; Anagnostopoulos C
    J Nucl Med; 2010 Jul; 51(7):1036-43. PubMed ID: 20554740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variation of ischemic response to exercise in patients receiving a once-daily dose of beta-blockers. Implications for exercise testing and prescription of exercise and training heart rates.
    Franklin BA; Gordon S; Timmis GC
    Chest; 1996 Jan; 109(1):253-7. PubMed ID: 8549193
    [No Abstract]   [Full Text] [Related]  

  • 13. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1996; 59(2):24-6. PubMed ID: 8974558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia.
    Crawford MH
    Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischemic therapy and stress testing: pathophysiologic, diagnostic and prognostic implications.
    Sicari R
    Cardiovasc Ultrasound; 2004 Aug; 2():14. PubMed ID: 15320951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging options in the management of myocardial ischemia.
    Mehta JL
    Am J Cardiol; 1994 Jan; 73(3):18A-27A. PubMed ID: 7906091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH
    Circulation; 1983 Jun; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent ischemia and beta-blockade.
    Egstrup K
    Circulation; 1991 Dec; 84(6 Suppl):VI84-92. PubMed ID: 1683614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.